ABIOMED/ US0036541003 /
2022-12-21 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
381.19USD | - | 346,755 Turnover: 132.07 mill. |
-Bid Size: - | -Ask Size: - | 17.18 bill.USD | - | 127.01 |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 6.4000 | 6.5000 | 6.8890 | 9.1270 | 23.1840 | ||||||
Intangible Assets | 0.0000 | 0.0000 | - | - | - | ||||||
Long-Term Investments | - | - | 41.7610 | 13.9960 | 1 | ||||||
Fixed Assets | - | - | 87.4410 | 118.2280 | 135.5390 | ||||||
Inventories | 11.1000 | 14.9000 | 13.9480 | 16.7740 | 26.7400 | ||||||
Accounts Receivable | 20.5000 | 22.9000 | 24.3570 | 31.8280 | 42.8210 | ||||||
Cash and Cash Equivalents | 6 | 9.5000 | 20.9160 | 22.4010 | 48.2310 | ||||||
Current Assets | 110.5000 | 116.6000 | 117.9660 | 220.1390 | 288.3920 | ||||||
Total Assets | 153.9000 | 170 | 205.4070 | 338.3670 | 423.9310 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 6.9000 | 7.7000 | 7.7460 | 10.3890 | 9.3810 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 4.8000 | 5.6000 | 6.4000 | .8000 | .8000 | ||||||
Liabilities | 27.6000 | 32.9000 | 37.0540 | 46.8070 | 55.1560 | ||||||
Share Capital | - | - | .4110 | .4130 | .4260 | ||||||
Total Equity | 126.3000 | 137.1000 | 168.3530 | 291.5600 | 368.7750 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 153.9000 | 170 | 205.4070 | 338.3670 | 423.9310 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 126.4000 | 158.1000 | 183.6430 | 230.3110 | 329.5430 | ||||||
Depreciation (total) | 1.5000 | .1000 | 2.5080 | 2.7700 | 3.2770 | ||||||
Operating Result | 1.5000 | 16.5000 | 8.3630 | 28.6660 | 65.1040 | ||||||
Interest Income | - | - | .1180 | .1960 | .3950 | ||||||
Income Before Taxes | 2.5000 | 16.9000 | 8.5300 | 28.7650 | 65.8380 | ||||||
Income Taxes | 1 | 1.8000 | 1.1790 | -84.9230 | 27.6910 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 1.5000 | 15 | 7.3510 | 113.6880 | 38.1470 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3.6000 | 26.4000 | 23.4660 | 43.2900 | 76.7950 | ||||||
Cash Flow from Investing Activities | -17.5000 | -10.3000 | -22.2720 | -49.8630 | -57.7100 | ||||||
Cash Flow from Financing | 14.7000 | -11.8000 | 9.6320 | 9.5230 | 7.1600 | ||||||
Decrease / Increase in Cash | .2000 | 3.5000 | 11.4650 | 1.4850 | 25.8300 | ||||||
Employees | 397 | 467 | 511 | 589 | 747 |